DexCom showed strong growth, margin expansion, and Stelo's OTC launch unlocked new markets despite competitive and regulatory ...

We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. DexCom, Inc. is one of them.

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include ...

ViCentra's Kaleido is "the smallest, thinnest, lightest, most precise insulin patch pump in its class," CEO Tom Arnold said ...

Shares of DexCom (DXCM) declined 10% on Friday after investment firm Hunterbrook Capital disclosed a short position in the stock. Hunterbrook said on Thursday that it has a short position on DXCM ...

In addition to the graphics and processor hardware requirements -- fairly meaningless for a handheld -- the always-on connection could be a sticking point. That is, you can't even play the campaign ...

GameSpot may get a commission from retail offers. After many years of waiting for a new entry in EA's popular skateboarding franchise, players can finally dive into the aptly-titled Skate. This reboot ...

Gearbox has confirmed it’s “exploring” how to add a field of view (FOV) slider to Borderlands 4 on PlayStation 5 and Xbox Series X and S after complaints from console players. When Borderlands 4 ...

Mojang has collaborated with Noxcrew to give away the Minecraft Owls add-on, a unique pack that brings the beloved avian creatures to the game. It adds unique variants of owls alongside an array of ...

Shares of medical device company DexCom (NASDAQ:DXCM) fell 7.4% in the morning session after a short-seller report from Hunterbrook Capital alleged issues with the company's G7 glucose monitoring ...

Microsoft Teams has become a central part of Office 365 as the software giant slowly rolls out a new feature where Teams can finally be found in the Microsoft Outlook email app. This is a big deal for ...

10 analysts have expressed a variety of opinions on DexCom (NASDAQ: DXCM) over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table summarizes their recent ...